Virtual Unenhanced Images of the Abdomen With Second-Generation Dual-Source Dual-Energy Computed TomographyCarlo N. De Cecco, Carmen Ayuso, Anna Darnell et al.|Investigative Radiology|2012Cited by 91
Second-Generation Dual-Energy Computed Tomography of the AbdomenCarlo N. De Cecco, Carmen Ayuso, Anna Darnell et al.|Journal of Computer Assisted Tomography|2013Cited by 27
Leiomyomatosis peritonealis disseminata (2006: 9b)Neus Ruscalleda, Jaume Ordï, E. Eixarch et al.|European Radiology|2006Cited by 11
Phase II trial of neoadjuvant mFOLFOX 6 with panitumumab (P) in T3 rectal cancer with clear mesorectal fascia (MRF) and <i>KRAS</i>, <i>NRAS</i>, <i>BRAF</i>, <i>PI3KCA</i> wild type (4WT). GEMCAD 1601 PIER trial.Carlos Fernández-Martos, Manuel Valladares, Ana Vivancos et al.|Journal of Clinical Oncology|2021Cited by 3
PIER trial: Neoadjuvant therapy with panitumumab (P) and mFOLFOX-6 in an enriched population of patients with T3 rectal adenocarcinoma of the middle third with clear mesorectal fascia.Carlos Fernández-Martos, Ruth Vera, Jorge Aparicio et al.|Journal of Clinical Oncology|2018Cited by 0